Trial Profile
A Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Aflibercept in Combination With Intravenous Irinotecan/5-Fluorouracil/Isovorin (FOLFIRI) Administered Every 2 Weeks in Patients With Metastatic Colorectal Cancer.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary) ; Fluorouracil; Irinotecan; Levofolinic acid
- Indications Colorectal cancer
- Focus Adverse reactions
- 19 Jul 2012 Actual number of patients changed from 22 to 16, as reported by ClinicalTrials.gov.
- 19 Jul 2012 Actual end date (Jun 2012) added as reported by ClinicalTrials.gov.
- 01 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.